Skip to main content

Table 1 Histopathological and clinical features in published series of patients with OFMT

From: Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor

Study Number of patients (total/FU) Histological subtype (T, A, M) Median follow-up (months) Follow-up information Outcome
Enzinger et al. [1] 59/41 N/A N/A 11 LR
1 DM
3 DoC
Folpe et al. [6] 70/51 N/A 36 9 LR
8 DM
41 NED
6 ED
4 DoD
1 DoC
Miettinen et al. [3] 104/41 N/A 156 9 LR 32 UNK
16 DoC
5 NED
Graham et al. [15] 46/27 T = 26
A = 5 
M = 15
55 2 LR (M)
3 DM (M)
3 DoD
Atanaskova Mesinkova et al. [4] 26/16 T = 8
A = 13 
M = 5
45 3 LR (M)
1 DM (M)
N/A
Kossivi Dantey et al. [5] 6/6 A = 1 
M = 5
27 No events 1 DoC
  1. FU follow-up, T typical, A atypical, M malignant, N/A not available, LR Local relapse, DM distant metastasis, DoC dead of other cause, NED not evident disease, ED evident disease, DoD dead of disease, UNK unknown